1
|
Joly CA, Reynard P, Mezzi K, Bakhos D, Bergeron F, Bonnard D, Borel S, Bouccara D, Coez A, Dejean F, Del Rio M, Leclercq F, Henrion P, Marx M, Mom T, Mosnier I, Potier M, Renard C, Roy T, Sterkers-Artières F, Venail F, Verheyden P, Veuillet E, Vincent C, Thai-Van H. Guidelines of the French Society of Otorhinolaryngology-Head and Neck Surgery (SFORL) and the French Society of Audiology (SFA) for Speech-in-Noise Testing in Adults. Eur Ann Otorhinolaryngol Head Neck Dis 2022; 139:21-27. [PMID: 34140263 DOI: 10.1016/j.anorl.2021.05.005] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
OBJECTIVES This document presents the fundamentals of speech audiometry in noise, general requirements for implementation and criteria for choice among the tests available in French according to the health-professional's needs. MATERIAL AND METHODS The recommendations are based on a systematic analysis of the literature carried out by a multidisciplinary group of doctors, audiologists and audioprosthetists from all over France. They are graded A, B, C or expert opinion according to decreasing level of scientific evidence. RESULTS Eight tests of speech audiometry in noise can be used in France. CONCLUSION To be complete, evaluation of hearing status requires testing understanding of speech in noise. The examination must begin with a minimum of two measurements familiarizing the subject with the test procedure. For initial diagnosis, adaptive procedures establishing the 50% speech reception threshold (SRT50) in noise are to be preferred in order to obtain a rapid and standardized measurement of perception of speech in noise. When the aim is to measure real-life speech comprehension, tests based on sentences, cocktail-party noise and free-field stimulation are to be preferred. Prosthetic gain is evaluated exclusively in free field. This is the only way to evaluate the contribution of binaurality and to measure perception in noise in an environment as close as possible to real life. In order to avoid acoustic interference in free field, at least five loudspeakers should be used, in particular for evaluating the effectiveness of directional microphones, CROS devices enabling sounds picked up in the damaged ear to be rerouted to the functional ear, or bimodal fitting (i.e., when hearing is enabled by two modalities: for example, hearing aid for one ear, cochlear implant for the other).
Collapse
Affiliation(s)
- C-A Joly
- Institut de l'Audition - Institut Pasteur, Inserm (French National Institute of Health and Medical Research), 75012 Paris, France; Department of Audiology and Otoneurological Evaluation, Edouard-Herriot Hospital, HCL (Hospices Civils de Lyon), 69003 Lyon, France
| | - P Reynard
- Institut de l'Audition - Institut Pasteur, Inserm (French National Institute of Health and Medical Research), 75012 Paris, France; Department of Audiology and Otoneurological Evaluation, Edouard-Herriot Hospital, HCL (Hospices Civils de Lyon), 69003 Lyon, France; Claude-Bernard University Lyon 1, 69100 Villeurbanne, France
| | - K Mezzi
- Department of Audiology and Otoneurological Evaluation, Edouard-Herriot Hospital, HCL (Hospices Civils de Lyon), 69003 Lyon, France
| | - D Bakhos
- Department of ENT and Head & Neck Surgery, University Hospital of Tours, 37000 Tours, France; iBrain, Inserm U1253, University of Tours, 37000 Tours, France
| | - F Bergeron
- Université Laval, Center for Interdisciplinary Research in Rehabilitation and Social Integration, G1V 0A6 Québec City, QC, Canada
| | - D Bonnard
- Institut de l'Audition - Institut Pasteur, Inserm (French National Institute of Health and Medical Research), 75012 Paris, France; Department of ENT, University Hospital of Bordeaux, 33000 Bordeaux, France
| | - S Borel
- Functional unit for auditory implants and audiovestibular testing, Department of Otorhinolaryngology, Ile de France reference centre for cochlear and brainstem implants in adults, Pitié-Salpêtrière Hospital Group, Sorbonne University, AP-HP, 75013 Paris, France
| | - D Bouccara
- Department of ENT and Head & Neck Oncology, Georges-Pompidou European Hospital, Paris Ouest University Hospitals, AP-HP, 75015 Paris, France
| | - A Coez
- Institut de l'Audition - Institut Pasteur, Inserm (French National Institute of Health and Medical Research), 75012 Paris, France; Laboratoire de correction auditive Eric Bizaguet, 750001 Paris, France
| | - F Dejean
- French Society of Audiology, 75116 Paris, France
| | - M Del Rio
- École d'Audioprothèse - Université de Bordeaux, 33000 Bordeaux, France; Caudéran Audition, 33200 Bordeaux, France
| | - F Leclercq
- Laboratoire d'Audiologie Renard, 59000 Lille, France; Department of Otology and Otoneurology, Salengro Hospital, University of Lille, 59000 Lille, France
| | - P Henrion
- French Society of Audiology, 75116 Paris, France
| | - M Marx
- Department of Otology, Otoneurology, and Paediatric Otorhinolaryngology, Pierre-Paul-Riquet Hospital, Toulouse Purpan University Hospital, 31000 Toulouse, France; Brain and Cognition Laboratory, UMR 5549, Toulouse III University, 31000 Toulouse, France
| | - T Mom
- Department of Otorhinolaryngology and Head & Neck Surgery, Gabriel-Montpied University Hospital, 63000 Clermont-Ferrand, France; Inserm UMR 1107, Sensorineural Biophysics Laboratory, Clermont-Auvergne University, 63000 Clermont-Ferrand, France
| | - I Mosnier
- Functional unit for auditory implants and audiovestibular testing, Department of Otorhinolaryngology, Ile de France reference centre for cochlear and brainstem implants in adults, Pitié-Salpêtrière Hospital Group, Sorbonne University, AP-HP, 75013 Paris, France
| | - M Potier
- Laboratoire d'Audiologie Clinique, 11100 Narbonne, France
| | - C Renard
- Laboratoire d'Audiologie Renard, 59000 Lille, France; Department of Otology and Otoneurology, Salengro Hospital, University of Lille, 59000 Lille, France
| | - T Roy
- Laboratoires F. Le Her, 76000 Rouen, France; Department of ENT and Head & Neck Surgery, Charles Nicolle University Hospital, 76000 Rouen, France
| | - F Sterkers-Artières
- Department of Audiophonology, Hôpital Institut Saint Pierre, 34250 Palavas Les Flots, France
| | - F Venail
- Department of ENT & Maxillofacial Surgery, Gui-de-Chauliac University Hospital, 34000 Montpellier, France; Inserm U1051, Institute for Neurosciences of Montpellier, University of Montpellier, 34000 Montpellier, France
| | - P Verheyden
- Department of Audiology, Haute Ecole Léonard de Vinci, Institut libre Marie Haps, Bruxelles, Belgium
| | - E Veuillet
- Institut de l'Audition - Institut Pasteur, Inserm (French National Institute of Health and Medical Research), 75012 Paris, France; Department of Audiology and Otoneurological Evaluation, Edouard-Herriot Hospital, HCL (Hospices Civils de Lyon), 69003 Lyon, France; Claude-Bernard University Lyon 1, 69100 Villeurbanne, France
| | - C Vincent
- Department of Otology and Otoneurology, Salengro Hospital, University of Lille, 59000 Lille, France
| | - H Thai-Van
- Institut de l'Audition - Institut Pasteur, Inserm (French National Institute of Health and Medical Research), 75012 Paris, France; Department of Audiology and Otoneurological Evaluation, Edouard-Herriot Hospital, HCL (Hospices Civils de Lyon), 69003 Lyon, France; Claude-Bernard University Lyon 1, 69100 Villeurbanne, France; French Society of Audiology, 75116 Paris, France.
| |
Collapse
|
2
|
Bergeron F, Rosenfeld P, Leung Y, Bressler B, Rosenfeld G. A118 FECAL CALPROTECTIN COMPLETION RATES AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE. J Can Assoc Gastroenterol 2019. [DOI: 10.1093/jcag/gwz006.117] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- F Bergeron
- Gastroenterology, University of British Columbia, Vancouver, BC, Canada
| | - P Rosenfeld
- Gastroenterology, University of British Columbia, Vancouver, BC, Canada
| | - Y Leung
- Gastroenterology, University of British Columbia, Vancouver, BC, Canada
| | - B Bressler
- Pacific Gastroenterology Associates, Vancouver, BC, Canada
| | | |
Collapse
|
3
|
Bergeron F, Boulende Sab A, Bouchard MF, Taniguchi H, Souchkova O, Brousseau C, Tremblay JJ, Pilon N, Viger RS. Phosphorylation of GATA4 serine 105 but not serine 261 is required for testosterone production in the male mouse. Andrology 2019; 7:357-372. [PMID: 30793514 DOI: 10.1111/andr.12601] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2018] [Revised: 01/28/2019] [Accepted: 01/30/2019] [Indexed: 12/11/2022]
Abstract
BACKGROUND GATA4 is a transcription factor essential for male sex determination, testicular differentiation during fetal development, and male fertility in the adult. GATA4 exerts part of its function by regulating multiple genes in the steroidogenic enzyme pathway. In spite of these crucial roles, how the activity of this factor is regulated remains unclear. OBJECTIVES Studies in gonadal cell lines have shown that GATA4 is phosphorylated on at least two serine residues-serine 105 (S105) and serine 261 (S261)-and that this phosphorylation is important for GATA4 activity. The objective of the present study is to characterize the endogenous role of GATA4 S105 and S261 phosphorylation in the mouse testis. MATERIALS AND METHODS We examined both previously described GATA4 S105A mice and a novel GATA4 S261A knock-in mouse that we generated by CRISPR/Cas9 gene editing. The male phenotype of the mutants was characterized by assessing androgen-dependent organ weights, hormonal profiles, and expression of multiple testicular target genes using standard biochemical and molecular biology techniques. RESULTS The fecundity of crosses between GATA4 S105A mice was reduced but without a change in sex ratio. The weight of androgen-dependent organs was smaller when compared to wild-type controls. Plasma testosterone levels showed a 70% decrease in adult GATA4 S105A males. This decrease was associated with a reduction in Cyp11a1, Cyp17a1, and Hsd17b3 expression. GATA4 S261A mice were viable and testis morphology appeared normal. Testosterone production and steroidogenic enzyme expression were not altered in GATA4 S261A males. DISCUSSION AND CONCLUSION Our analysis showed that blocking GATA4 S105 phosphorylation is associated with decreased androgen production in males. In contrast, S261 phosphorylation by itself is dispensable for GATA4 function. These results confirm that endogenous GATA4 action is essential for normal steroid production in males and that this activity requires phosphorylation on at least one serine residue.
Collapse
Affiliation(s)
- F Bergeron
- Reproduction, Mother and Child Health, Centre de Recherche du CHU de Québec-Université Laval, Quebec, QC, Canada.,Centre de Recherche en Reproduction, Développement et Santé Intergénérationnelle (CRDSI), Quebec, QC, Canada
| | - A Boulende Sab
- Département des Sciences Biologiques and Centre d'excellence en Recherche sur les Maladies Orphelines - Fondation Courtois (CERMO-FC), Université du Québec à Montréal (UQAM), Montreal, QC, Canada
| | - M F Bouchard
- Reproduction, Mother and Child Health, Centre de Recherche du CHU de Québec-Université Laval, Quebec, QC, Canada.,Centre de Recherche en Reproduction, Développement et Santé Intergénérationnelle (CRDSI), Quebec, QC, Canada
| | - H Taniguchi
- Institute of Genetics and Animal Breeding of the Polish Academy of Sciences, Jastrzebiec, Poland
| | - O Souchkova
- Département des Sciences Biologiques and Centre d'excellence en Recherche sur les Maladies Orphelines - Fondation Courtois (CERMO-FC), Université du Québec à Montréal (UQAM), Montreal, QC, Canada
| | - C Brousseau
- Reproduction, Mother and Child Health, Centre de Recherche du CHU de Québec-Université Laval, Quebec, QC, Canada.,Centre de Recherche en Reproduction, Développement et Santé Intergénérationnelle (CRDSI), Quebec, QC, Canada
| | - J J Tremblay
- Reproduction, Mother and Child Health, Centre de Recherche du CHU de Québec-Université Laval, Quebec, QC, Canada.,Centre de Recherche en Reproduction, Développement et Santé Intergénérationnelle (CRDSI), Quebec, QC, Canada.,Department of Obstetrics, Gynecology, and Reproduction, Université Laval, Quebec, QC, Canada
| | - N Pilon
- Département des Sciences Biologiques and Centre d'excellence en Recherche sur les Maladies Orphelines - Fondation Courtois (CERMO-FC), Université du Québec à Montréal (UQAM), Montreal, QC, Canada
| | - R S Viger
- Reproduction, Mother and Child Health, Centre de Recherche du CHU de Québec-Université Laval, Quebec, QC, Canada.,Centre de Recherche en Reproduction, Développement et Santé Intergénérationnelle (CRDSI), Quebec, QC, Canada.,Department of Obstetrics, Gynecology, and Reproduction, Université Laval, Quebec, QC, Canada
| |
Collapse
|
4
|
Bergeron F, Hussaini T, Chandok N, Yoshida E. Alternative medicine products causing acute liver injury: Pandora’s box is open. CanLivJ 2019; 2:1-3. [DOI: 10.3138/canlivj.2018-0022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/09/2018] [Accepted: 01/09/2019] [Indexed: 11/20/2022]
Abstract
The regulatory loopholes governing alternative medicine products in Canada represent a public safety issue. In 2017 and 2018, the Liver Transplant Program of the University of British Columbia assessed three patients with acute liver failure secondary to alternative medicines. As health care professionals, we have a duty to both recognize the magnitude of the problem and advocate for reform of the current regulatory process for alternative medicine products.
Collapse
Affiliation(s)
- Fanny Bergeron
- Division of Gastroenterology, Vancouver General Hospital, Vancouver, British Columbia
| | - Trana Hussaini
- Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia
| | - Natasha Chandok
- Department of Medicine, Division of Gastroenterology, William Osler Health Centre, Brampton, Ontario
- Adjunct Professor of Medicine, University of Western Ontario, London, Ontario
- Clinical Affiliate, University of Manitoba, Winnipeg, Manitoba
| | - Eric M Yoshida
- Department of Hepatology, Vancouver General Hospital, Vancouver British Columbia
- Division of Gastroenterology, University of British Columbia, Vancouver, British Columbia
| |
Collapse
|
5
|
Bergeron F, Presse N, D’Aoust L, Lemoyne M, Bouin M. A143 FOOD AVOIDANCE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: WHAT, WHEN AND WHO? J Can Assoc Gastroenterol 2018. [DOI: 10.1093/jcag/gwy008.144] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- F Bergeron
- Internal Medecine, Université de Montréal, Montreal, QC, Canada
| | - N Presse
- Univeristé de Montreal, Montreal, QC, Canada
| | - L D’Aoust
- Univeristé de Montreal, Montreal, QC, Canada
| | - M Lemoyne
- Univeristé de Montreal, Montreal, QC, Canada
| | - M Bouin
- Université de Montreal, Montreal, QC, Canada
| |
Collapse
|
6
|
Bergeron F, Bouin M, D'Aoust L, Lemoyne M, Presse N. Food avoidance in patients with inflammatory bowel disease: What, when and who? Clin Nutr 2017; 37:884-889. [PMID: 28359542 DOI: 10.1016/j.clnu.2017.03.010] [Citation(s) in RCA: 34] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/14/2016] [Revised: 02/24/2017] [Accepted: 03/08/2017] [Indexed: 12/15/2022]
Abstract
BACKGROUND & AIMS Patients with inflammatory bowel diseases avoid a variety of foods. However, it remains unclear how this behavior varies across patients. This cross-sectional study investigated how the food avoidance pattern in inflammatory bowel disease varies according to disease's activity, disease's subtype, Crohn's location, and prior history of bowel resection, strictures, and fistulae. METHODS Outpatients with Crohn's disease (n = 173) and ulcerative colitis (n = 72) reported which food they avoid when they perceive they are in remission or in active disease using a list of 82 food items classified in 10 categories. Medical charts were reviewed for patients' characteristics. Linear regression analyses were used to compare food exclusion rates between patients' subgroups and food categories. RESULTS During remission, food exclusion rates varied from 1 to 39%. Most avoided foods were those with capsaicin, meat alternatives, and raw vegetables. Overall, food exclusion rates were 38% higher in Crohn's disease than ulcerative colitis (P < 0.001), and 50% higher in stricturing than non-stricturing Crohn's disease (P < 0.001). During active disease, food exclusion rates were 69% higher than in remission (P < 0.001). Similar differences between subgroups were again observed during active disease though less noticeable than in remission. No association was found with other disease characteristics. Avoided foods were very similar across patients except for alcoholic beverages and foods rich in dietary fibers/residue, which were avoided more specifically during active disease and in Crohn's disease, respectively. CONCLUSIONS Food avoidance is common among patients with inflammatory bowel diseases, and most particularly in those with stricturing Crohn's disease. Specificities in avoidance pattern suggest that the clinical response to dietary restrictions may differ according to the disease's characteristics.
Collapse
Affiliation(s)
- Fanny Bergeron
- Département de Médecine, Faculté de Médecine, Université de Montréal, Montréal, QC, Canada.
| | - Mickael Bouin
- Département de Médecine, Faculté de Médecine, Université de Montréal, Montréal, QC, Canada; Service de gastroentérologie, Hôpital St-Luc, Centre hospitalier de l'Université de Montréal, Montréal, QC, Canada; Centre de Recherche, Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada.
| | - Louise D'Aoust
- Département de Médecine, Faculté de Médecine, Université de Montréal, Montréal, QC, Canada; Service de gastroentérologie, Hôpital St-Luc, Centre hospitalier de l'Université de Montréal, Montréal, QC, Canada.
| | - Michel Lemoyne
- Département de Médecine, Faculté de Médecine, Université de Montréal, Montréal, QC, Canada; Service de gastroentérologie, Hôpital St-Luc, Centre hospitalier de l'Université de Montréal, Montréal, QC, Canada.
| | - Nancy Presse
- Département de nutrition, Faculté de Médecine, Université de Montréal, Montréal, QC, Canada; Centre de recherche, Institut universitaire de gériatrie de Montréal, Montréal, QC, Canada.
| |
Collapse
|
7
|
Baba N, Van VQ, Wakahara K, Rubio M, Fortin G, Panzini B, Soucy G, Wassef R, Richard C, Tamaz R, Lahaie R, Bernard EJ, Caussignac Y, Leduc R, Lougnarath R, Bergeron C, Racicot MA, Bergeron F, Panzini MA, Demetter P, Franchimont D, Schäkel K, Weckbecker G, Kolbinger F, Heusser C, Huber T, Welzenbach K, Sarfati M. CD47 fusion protein targets CD172a+ cells in Crohn's disease and dampens the production of IL-1β and TNF. ACTA ACUST UNITED AC 2013; 210:1251-63. [PMID: 23669395 PMCID: PMC3674701 DOI: 10.1084/jem.20122037] [Citation(s) in RCA: 38] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
CD172a+ cells producing IL-1β and TNF are increased in inflamed tissues in Crohn’s disease and can be targeted by CD47 fusion protein. In mice, the transfer of CD172a+ (SIRP-α) dendritic cells (DCs) elicits T cell–driven colitis, whereas treatment with CD47-Fc protein, a CD172a-binding agent, confers protection. The aim of this study was to elucidate the nature and functional properties of human CD172a+ DCs in chronic intestinal inflammation. Here, we show that CD172a+CD11c+ cells accumulate in the mesenteric lymph nodes (mLNs) and inflamed intestinal mucosa in patients with Crohn’s disease (CD). These cells are distinct from resident DCs and may coexpress markers typically associated with monocyte-derived inflammatory DCs such as CD14 and/or DC-SIGN, E-Cadherin, and/or CX3CR1. Spontaneous IL-1β and TNF production by HLA-DR+ cells in CD tissues is restricted to those expressing CD172a. An avidity-improved CD47 fusion protein (CD47-Var1) suppresses the release of a wide array of inflammatory cytokines by CD172a+ cells, which may include HLA-DR−CD172a+ neutrophils, in inflamed colonic explant cultures and impairs the ability of HLA-DR+CD172a+ cells to activate memory Th17 but not Th1 responses in mLNs. In conclusion, targeting CD172a+ cells may represent novel therapeutic perspectives for patients with CD.
Collapse
Affiliation(s)
- Nobuyasu Baba
- Immunoregulation Laboratory, The Research Center of the Centre Hospitalier de L'Université de Montréal (CRCHUM), Montreal, Canada
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
8
|
Bergeron F, Astruc C, Berry A, Masson P. Sound Quality Assessment of Internal Automotive Road Noise Using Sensory Science. ACTA ACUST UNITED AC 2010. [DOI: 10.3813/aaa.918308] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|
9
|
Abstract
Recent work suggests that once the auditory cortex of deaf persons has been reorganized by cross-modal plasticity, it can no longer respond to signals from a cochlear implant (CI) installed subsequently. To further examine this issue, we compared the evoked potentials involved in the processing of visual stimuli between CI users and hearing controls. The stimuli were concentric circles replaced by a different overlapping shape, inducing a shape transformation, known to activate the ventral visual pathway in human adults. All CI users had their device implanted for >1 year, but obtained different levels of auditory performance following training to establish language comprehension. Seven of the 13 patients showed good capacities for speech recognition with the CI (good performers) while the six others demonstrated poor speech recognition abilities (poor performers). The evoked potentials of all patients showed larger amplitudes, with different distributions of scalp activations between the two groups. The poor performers exhibited broader, anteriorly distributed, high P2 amplitudes over the cortex whereas the good performers showed significantly higher P2 amplitudes over visual occipital areas. These results suggest the existence of a profound cross-modal reorganization in the poor performers and an intramodal reorganization in the good performers. We interpret these data on the basis of enhanced audiovisual coupling as the key to a long-term functional improvement in speech discrimination in CI users.
Collapse
Affiliation(s)
- M E Doucet
- Centre de Recherche en Neuropsychologie et Cognition, Université de Montréal, Montréal, Canada
| | | | | | | | | |
Collapse
|
10
|
Bergeron F, Ferron P. Utility of ear implants: can all benefits be valued? Cochlear Implants Int 2005; 6 Suppl 1:2-3. [DOI: 10.1179/cim.2005.6.supplement-1.2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/31/2022]
|
11
|
Doucet ME, Bergeron F, Lepore F. Neurophysiological changes in the visual cortex after cochlear implantation. J Vis 2005. [DOI: 10.1167/5.8.886] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
12
|
Bergeron F, Ferron P. Utility of ear implants: can all benefits be valued? Cochlear Implants Int 2005. [DOI: 10.1002/cii.268] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
|
13
|
Bergeron F. Residual hearing following a cochlear implantation: effect of time and device. Adv Otorhinolaryngol 2002; 57:389-92. [PMID: 11892197 DOI: 10.1159/000059188] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/24/2023]
Affiliation(s)
- F Bergeron
- Quebec Cochlear Implant Program, Institut de réadaptation en déficience physique de Québec, Charlesbourg, Canada.
| |
Collapse
|
14
|
Trinh BT, Bergeron F, Ferron P. Long-term follow-up of cochlear implant users with ossified cochlea. J Otolaryngol 2000; 29:279-84. [PMID: 11108486] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/18/2023]
Abstract
OBJECTIVE Cochlear implantation surgery in ossified cochlea is a challenge, even for the experienced otologist. Short-term assessments of auditory perception show that implantation in partial or even extensive ossified cochlea could be achieved with varying success, but no long-term follow-up results have been published yet. DESIGN AND METHODS This paper proposes a retrospective review of eight Nucleus cochlear implant users with ossified cochlea who have been followed on a 12- to 60-month period. MAIN OUTCOME MEASURE Auditory performances of users are reported at each control on a scale of 100 units divided into 4 skill zones of 25 units based on Erber's proposition, that is, detection, discrimination, identification, and recognition. RESULTS Three of the eight subjects showed some progression in their auditory performances during the follow-up. The five other subjects showed no long-term progress in their auditory performance. CONCLUSIONS Open-set comprehension could be achieved with the insertion of 9 to 10 electrodes of the Nucleus device. Auditory performance in users with ossified cochlea seems to be influenced by the same factors as in users with patent cochlea.
Collapse
Affiliation(s)
- B T Trinh
- Centre Hospitalier Universitaire de Québec, Pavillon Hôtel-Dieu de Québec. Québec
| | | | | |
Collapse
|
15
|
Hubert P, Bergeron F, Ferreira V, Seligmann M, Oksenhendler E, Debre P, Autran B. Defective p56Lck activity in T cells from an adult patient with idiopathic CD4+ lymphocytopenia. Int Immunol 2000; 12:449-57. [PMID: 10744646 DOI: 10.1093/intimm/12.4.449] [Citation(s) in RCA: 51] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Idiopathic CD4(+) lymphocytopenia (ICL) is defined by a stable loss of CD4(+) T cells in the absence of any known cause of immune deficiency. This syndrome is still of undetermined origin. It affects adult patients, some of them displaying opportunistic infections similar to HIV-infected subjects. The hypothesis that the cellular immune defect may be due to biochemical failures of the CD3-TCR pathway is investigated here in a patient associating a severe selective CD4(+) lymphocytopenia with an increased CD8(+) T cell count discovered in the course of a cryptococcal meningitidis. A 40% reduction of T cell proliferation to CD3-TCR stimulation is observed only in the CD4(+) subpopulation. The early CD3-induced protein tyrosine phosphorylations are conserved in both CD4(+) and CD8(+) subsets, and the levels of the T cell protein tyrosine kinases p56(Lck), p59(Fyn) and ZAP-70 are normal. However, we find a 50% reduction of p56(Lck) kinase activity in the patient's T cells compared to a healthy control donor. p59(Fyn) activity does not appear to be altered. Nevertheless, we do not find any genetic abnormality of p56(Lck). These results thus suggest that a defect of an unknown protein regulating p56(Lck) activity takes place in this patient's T cells. Taken together, these findings reveal p56(Lck) alteration in ICL and confirm the critical role of this kinase in the maintenance of the peripheral CD4(+) T cell subpopulation.
Collapse
Affiliation(s)
- P Hubert
- Laboratoire d'Immunologie Cellulaire, CNRS UMR 7627, CHU Pitié-Salpétrière, 83 Boulevard de l'Hôpital, 75651 Paris Cedex 13, France
| | | | | | | | | | | | | |
Collapse
|
16
|
Abstract
Limited proteolysis of most large protein precursors is carried out in vivo by the subtilisin-like pro-protein convertases. Many important biological processes such as peptide hormone synthesis, viral protein processing and receptor maturation involve proteolytic processing by these enzymes, making them potential targets for the development of novel therapeutic agents. However, the efficient development of such molecules requires a better understanding of the molecular mechanisms of proteolytic protein processing. Herein, we review the most recent findings on the molecular aspects of subtilisin-like convertase activity, such as the structural analysis of the proteases, the mechanisms of enzyme/substrate specificity, their interaction with other proteins such as 7B2, and the comparative tissue and cellular distribution of the enzymes and their substrates. These data are then used as a background for the review of the known biological functions of subtilisin-like pro-protein convertases, the reported clinical cases involving proteolytic processing defects and, finally, the ongoing development of new therapeutic inhibitor molecules based on this knowledge.
Collapse
Affiliation(s)
- F Bergeron
- Département de Pharmacologie, Institut de Pharmacologie de Sherbrooke, Université de Sherbrooke, 3001, 12e Avenue Nord Sherbrooke, Québec, Canada J1H 5N4
| | | | | |
Collapse
|
17
|
Dalle S, Smith P, Blache P, Le-Nguyen D, Le Brigand L, Bergeron F, Ashcroft FM, Bataille D. Miniglucagon (glucagon 19-29), a potent and efficient inhibitor of secretagogue-induced insulin release through a Ca2+ pathway. J Biol Chem 1999; 274:10869-76. [PMID: 10196164 DOI: 10.1074/jbc.274.16.10869] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
Using the MIN6 B-cell line, we investigated the hypothesis that miniglucagon, the C-terminal () fragment processed from glucagon and present in pancreatic A cells, modulates insulin release, and we analyzed its cellular mode of action. We show that, at concentrations ranging from 0.01 to 1000 pM, miniglucagon dose-dependently (ID50 = 1 pM) inhibited by 80-100% the insulin release triggered by glucose, glucagon, glucagon-like peptide-1-(7-36) amide (tGLP-1), or glibenclamide, but not that induced by carbachol. Miniglucagon had no significant effects on cellular cAMP levels. The increase in 45Ca2+ uptake induced by depolarizing agents (glucose or extracellular K+), by glucagon, or by the Ca2+channel agonist Bay K-8644 was blocked by miniglucagon at the doses active on insulin release. Electrophysiological experiments indicated that miniglucagon induces membrane hyperpolarization, probably by opening potassium channels, which terminated glucose-induced electrical activity. Pretreatment with pertussis toxin abolished the effects of miniglucagon on insulin release. It is concluded that miniglucagon is a highly potent and efficient inhibitor of insulin release by closing, via hyperpolarization, voltage-dependent Ca2+ channels linked to a pathway involving a pertussis toxin-sensitive G protein.
Collapse
Affiliation(s)
- S Dalle
- INSERM U376, CHU Arnaud-de-Villeneuve, 34295 Montpellier, France
| | | | | | | | | | | | | | | |
Collapse
|
18
|
Mollet L, Fautrel B, Leblond V, Bergeron F, Merle-Béral H, Baumelou E, Hubert P, Debré P, Autran B. Leukemic CD3+ LGL share functional properties with their CD8+ CD57+ cell counterpart expanded after BMT. Leukemia 1999; 13:230-40. [PMID: 10025897 DOI: 10.1038/sj.leu.2401266] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
Leukemic T-LGL (large granular lymphocyte) composed of clonal CD3+ TCR alphabeta+ CD8+ CD57+ cells were compared with oligoclonally CD3+ CD8hi+ CD57- lymphocytes expanded after BMT. Leukemic CD3+ CD8hi+ CD57+ LGL showed several phenotypic differences such as an upregulation of CD16 and adhesion molecules (mainly CD11c, CD58 and CD54), activation markers and an exclusive CD45RA isoform expression. Unstimulated CD3+ CD8+ CD57+ LGL from both leukemic and BMT donors spontaneously developed an ex vivo CTL-like CD3-redirected cytotoxicity but no NK cell activity. Different stimuli (PHA, PMA or rhIL-2) induced similar cytotoxic profiles after a 6-day culture involving a CD3-redirected lysis predominating over a low NK cell activity. However, culture of leukemic LGL with these stimuli allowed either a 2 week persistence (PMA or rhIL-2) of CD8+ CD57+ LGL or their disappearance after 3 days (PHA). Furthermore, leukemic CD8hi+ CD57+ T lymphocytes produced an inhibitor of cytotoxic functions as previously described for BMT recipients' CD8+ CD57+ cells. Thus, despite some phenotypic differences between both cell sources, leukemic CD57+ T-LGL display the same functional characteristics of cytotoxic effector and immunoregulatory T cells as CD8+ CD57+ T cells from BMT recipients which might represent their normal counterpart.
Collapse
Affiliation(s)
- L Mollet
- Laboratoire d'Immunologie Cellulaire et Tissulaire, CNRS-UMR 7627, Hôpital Pitié-Salpétriêre, Paris, France
| | | | | | | | | | | | | | | | | |
Collapse
|
19
|
Hubert P, Bergeron F, Grenot P, Seligman M, Krivitzky A, Debré P, Autran B. [Deficiency of the CD3-TCR signal pathway in three patients with idiopathic CD4+ lymphocytopenia]. J Soc Biol 1999; 193:11-6. [PMID: 10851550] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/14/2023]
Abstract
Idiopathic CD4+ lymphocytopenia (ICL) is a rare syndrome affecting adults and defined by a stable loss of CD4+ T cells in the absence of any known cause of immune deficiency. Defective T-cell proliferations to mitogens and antigens have been described in some of such patients displaying clinical signs of immune deficiency such as opportunistic infections. We investigated here the hypothesis that T-cell depletion and dysfunction could be due to biochemical defects of the CD3-TCR pathway in CD4+ and/or CD8+ subsets from three patients with severe stable ICL (below 150 CD4+ T cells/microliter) and opportunistic infections. Patient 1 had a general T lymphocytopenia, whereas patients 2 and 3 displayed a selective loss of CD4+ T cells. We observed in all patients a major reduction of the proliferative response to CD3-TCR stimulation that affected only the depleted T-cell subpopulation. Moreover, in two cases, impaired early biochemical events of the CD3-TCR pathway were detected. In patient 1 and 3, we found a defect (of distinct intensity) of CD3-induced protein tyrosine phosphorylation in CD4+ cells compared to control cells, whereas this process was normally induced in CD4+ T cells from patient 2. Taken together, this study reveals that the heterogeneity of the ICL syndrome was situated at the cellular level, and involved in two cases abnormalities of transducing molecules of the CD3-TCR pathway.
Collapse
Affiliation(s)
- P Hubert
- Laboratoire d'Immunologie Cellulaire, CNRS UMR 7627, Hôpital Pitié-Salpêtrière, Paris, France
| | | | | | | | | | | | | |
Collapse
|
20
|
Bergeron F, Otto A, Blache P, Day R, Denoroy L, Brandsch R, Bataille D. Molecular cloning and tissue distribution of rat sarcosine dehydrogenase. Eur J Biochem 1998; 257:556-61. [PMID: 9839943 DOI: 10.1046/j.1432-1327.1998.2570556.x] [Citation(s) in RCA: 32] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
Sarcosine dehydrogenase (SarDH) is a mitochondrial flavoenzyme involved in the oxidative degradation of choline to glycine. The absence of SarDH activity in humans is genetically transmitted and is the cause of an amino acid metabolism disorder called sarcosinemia. Tryptic fragments of the purified enzyme from rat liver were subjected to Edman degradation and the sequences obtained were used to clone the cDNA encoding the full length protein. The deduced amino acid sequence of SarDH shares an overall similarity of 47% with dimethylglycine dehydrogenase (Me2GlyDH), another flavoenzyme involved in the mitochondrial choline catabolism with a similar FAD-binding domain. Covalent binding of FAD to SarDH was demonstrated by the observation of strong fluorescence at 530 nm under excitation at 450 nm of the enzyme immunoprecipitated under denaturing conditions from liver extracts. The localization of SarDH immunoreactivity in the mitochondrial matrix was confirmed by Western-blot analysis of purified mitochondrial fractions. Finally, the tissue distribution of SarDH was investigated by Northern-blot analysis of total RNA and Western-blot analysis of total protein from several rat tissues. A strong expression in the liver, but also in the lung, pancreas, kidney, thymus, and oviduct was observed. We therefore suggest that the enzymes of the choline catabolism pathway are important also for metabolism in nonhepatic tissues.
Collapse
Affiliation(s)
- F Bergeron
- INSERM U376, CHU Arnaud de Villeneuve, Montpellier, France
| | | | | | | | | | | | | |
Collapse
|
21
|
Bataille D, Dalle S, Blache P, Bergeron F. [Post-translational maturation of proglucagon: variations in tissues and regulation pathways]. Journ Annu Diabetol Hotel Dieu 1998:127-40. [PMID: 9773615] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/09/2023]
Affiliation(s)
- D Bataille
- INSERM U 376, CHU Arnaud-de-Villeneuve, Montpellier, France
| | | | | | | |
Collapse
|
22
|
Mollet L, Sadat-Sowti B, Duntze J, Leblond V, Bergeron F, Calvez V, Katlama C, Debré P, Autran B. CD8hi+CD57+ T lymphocytes are enriched in antigen-specific T cells capable of down-modulating cytotoxic activity. Int Immunol 1998; 10:311-23. [PMID: 9576619 DOI: 10.1093/intimm/10.3.311] [Citation(s) in RCA: 61] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023] Open
Abstract
Major expansions of CD8hi+CD57+ T lymphocytes frequently occur during human immunodeficiency virus (HIV) infection and after transplantation. To investigate mechanisms of such cell expansion, we compared the activation and functional status of CD8hi+CD57+ and CD57-peripheral blood lymphocytes (PBL) from normal, bone marrow transplantation (BMT) and HIV+ donors. The CD8hi+CD57+ PBL from BMT and HIV+ donors preferentially displayed CD38 and HLA-DR activation markers without correlation between CD8hi+CD57+ percentages and HIV load, the CD45RA+ isoform in all ex vivo conditions but acquired CD45RO after in vitro expansion, CD11b and CD11c in BMT and HIV+ donors but decreased expression of CD62-L, VLA-2 and VLA-6. The CD8hi+CD57+ cells were positive for perforin and granzyme B and spontaneously mediated cytolytic activity in a CD3-redirected assay. In contrast the inhibitor of cytolytic functions (ICF) produced by CD8hi+CD57+ cells down-modulated the CD3-redirected cytolytic activity but only at low levels of CD3 cross-linking. While CD3-triggering induced a low, if any, short-term proliferation of CD8+CD57+ cells, this subset could be amplified after long-term stimulation either with mitogens or with HIV antigens, thereby enriched in HIV-specific T cells producing tumor necrosis factor-alpha. Altogether these data suggest that CD8hi+CD57+ cells represent a terminal differentiation state of activated effector cytotoxic T lymphocytes which are enriched in antigen-specific T cells and down-modulate their own cytolytic potential, thus participating in a negative control of effector cell functions during persistent viral infections or transplantations.
Collapse
Affiliation(s)
- L Mollet
- Laboratoire d'Immunologie Cellulaire et Tissulaire, CNRS-URA 625, CHU Pitié-Salpétriêre, Paris, France
| | | | | | | | | | | | | | | | | |
Collapse
|
23
|
|
24
|
Affiliation(s)
- D Bataille
- INSERM U 376, CHU Arnaud-de-Villeneuve, Montpellier, France.
| | | | | |
Collapse
|
25
|
Blamey P, Arndt P, Bergeron F, Bredberg G, Brimacombe J, Facer G, Larky J, Lindström B, Nedzelski J, Peterson A, Shipp D, Staller S, Whitford L. Factors affecting auditory performance of postlinguistically deaf adults using cochlear implants. Audiol Neurootol 1996; 1:293-306. [PMID: 9390810 DOI: 10.1159/000259212] [Citation(s) in RCA: 266] [Impact Index Per Article: 9.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023] Open
Abstract
A model of auditory performance and a model of ganglion cell survival in postlinguistically deafened adult cochlear implant users are suggested to describe the effects of aetiology, duration of deafness, age at implantation, age at onset of deafness, and duration of implant use. The models were compared with published data and a composite data set including 808 implant users. Qualitative agreement with the model of auditory performance was found. Duration of deafness had a strong negative effect on performance. Age at implantation had a slight negative effect on performance, increasing after age 60 years. Age at onset of deafness had little effect on performance up to age 60. Duration of implant use had a positive effect on performance. Aetiology had a relatively weak effect on performance.
Collapse
Affiliation(s)
- P Blamey
- Department of Otolaryngology, University of Melbourne, East Melbourne, Vic., Australia
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
26
|
Paquet L, Bergeron F, Boudreault A, Seidah NG, Chrétien M, Mbikay M, Lazure C. The neuroendocrine precursor 7B2 is a sulfated protein proteolytically processed by a ubiquitous furin-like convertase. J Biol Chem 1994; 269:19279-85. [PMID: 8034690] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023] Open
Abstract
The neuroendocrine granule-associated protein 7B2, unlike many other neuroendocrine precursor proteins stored in secretory granules, carries in its primary structure the Arg-Xaa-Arg/Lys-Arg processing site usually found in constitutively secreted precursor proteins and recognized by the ubiquitously expressed convertase, furin. pro7B2 (30 kDa), when expressed in endocrine (AtT-20, PC12, and GH4C1) or non-endocrine (Ltk-) cell lines using recombinant vaccinia viruses, was converted to a 23-kDa form. Mutation of the P4 Arg to Gly completely prevented this conversion. When excess pro7B2 was coexpressed with the pro-protein convertases PC1, PC2, or furin, only furin could induce complete processing. In addition, coexpression of pro7B2 in LoVo cells, which are devoid of endogenous furin activity, with each one of the three convertases, showed that only furin was able to induce processing of this precursor. pro7B2 processing in AtT-20 was completely abolished when protein transport into Golgi compartments was blocked by cell incubation at either 15 or 37 degrees C in the presence of monensin or brefeldin A. Furthermore, pulse-chase experiments in the presence of Na2[35S]SO4 showed that pro7B2 is Tyr-sulfated in the trans-Golgi network before it is processed. These results demonstrate that pro7B2 is first processed by a furin-like enzyme within the trans-Golgi network into a 23-kDa form that is then sequestered into secretory granules.
Collapse
Affiliation(s)
- L Paquet
- Laboratory of Structure and Metabolism of Neuropeptides, Clinical Research Institute of Montréal, University of Montréal, Québec, Canada
| | | | | | | | | | | | | |
Collapse
|
27
|
Bergeron F. [A baccalaureate program conceived for nurses]. Nurs Que 1992; 12:27-9. [PMID: 1436823] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
|
28
|
Durieux C, Ruiz-Gayo M, Corringer PJ, Bergeron F, Ducos B, Roques BP. [3H]pBC 264, a suitable probe for studying cholecystokinin-B receptors: binding characteristics in rodent brains and comparison with [3H]SNF 8702. Mol Pharmacol 1992; 41:1089-95. [PMID: 1614411] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022] Open
Abstract
[3H]Propionyl-Tyr-(SO3H)-gNle-mGly-Trp-(NMe)Nle-Asp-Phe-NH2 ([3H]pBC 264) (98-100 Ci/mmol), a new peptidase-resistant cholecystokinin (CCK) agonist that is 1000-fold more potent for CCK-B than for CCK-A receptors, interacts, with a similar subnanomolar affinity, with a single class of binding sites (Kd, 0.15-0.2 nM) in brain membranes of mouse, rat, guinea pig, and cat, in Tris and Krebs buffers. The concentration of CCK-A receptors in rodent brain was estimated to be 8-10 fmol/mg of protein, by measurement of the Bmax values of the nonselective agonist [3H] propionyl-CCK8, with or without 10 nM pBC 264 to saturate CCK-B sites. In guinea pig and mouse brain, specific [3H]pBC 264 binding was not affected by NaCl and/or guanyl-5'-yl-imidodiphosphate. In contrast, in rat brain the affinity of [3H]pBC 264 was decreased and the maximal number of binding sites was increased by NaCl and the guanyl nucleotide or by alkaline treatment, suggesting that a proportion of CCK-B receptors are linked to guanine nucleotide-binding proteins. The Bmax of a CCK8 analog, [3H]SNF 8702, was higher (57 fmol/mg of protein) than that of [3H]pBC 264 (40 fmol/mg of protein) in guinea pig brain cortex but not in mouse brain. The relative potencies of various analogs differed among species. The CCK-B antagonist L365,260 was 18-, 30-, and 64-fold less potent than [3H]pBC 264 in guinea pig, mouse, and rat, respectively. PD 134308, a CCK-B antagonist, was 20-fold less potent in rat brain than in guinea pig brain. Likewise, the cyclic analog BC 254 displayed a 30- and 60-fold lower affinity for mouse and rat than for guinea pig brain preparations. Together, these results suggest the presence of CCK-B receptor subtypes. In all tissues, the specific binding of [3H]pBC 264 at its Kd values was very high (75-90%) and higher than that of the hydrophobic CCK-B probe [3H]SNF 8702 (approximately 50%). Therefore, unlike [3H]SNF 8702, [3H]pBC 264 can be used to study preparations with low receptor concentrations, such as rat brain, making this radiolabeled molecule the most appropriate ligand available to date for CCK-B receptor studies.
Collapse
Affiliation(s)
- C Durieux
- Département de Chimie Organique, U266 INSERM, URA 1500 CNRS, Paris, France
| | | | | | | | | | | |
Collapse
|
29
|
Picard M, Ferron P, Rochette C, Meyer F, Bergeron F, Blaney D, Desgagné M. [Multivariate study of auditory perception using multi-electrode cochlear implants]. J Otolaryngol 1992; 21:115-25. [PMID: 1583705] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Abstract
The goal of this study was to determine the influence of auditory and cognitive factors in hearing or listening mechanisms with the Nucleus multielectrode cochlear implant. Accordingly, hearing sensitivity, psycho-acoustical masking functions and measures of temporal resolution were obtained from 14 adults with acquired deafness. In addition, six measures of open-set speech discrimination were introduced to represent a possible contribution of cognitive factors. Results indicated the contribution of both auditory and cognitive factors to speech understanding. Cognitive factors were most influential. Differences were also found in the relative importance of various cognitive factors, both before and after an intensive aural rehabilitation program. Initially, subjects relied more heavily on their ability to make efficient use of the linguistic redundancy of speech. At the end of the program, they paid more attention to speech acoustics, as a result of enhanced auditory spectral analysis and temporal resolution at about 2 kHz.
Collapse
Affiliation(s)
- M Picard
- Université de Montréal, Québec, Canada
| | | | | | | | | | | | | |
Collapse
|
30
|
|
31
|
Bergeron F, Ferron P. [Development of auditory handicap after a multi-electrode cochlear implantation]. Union Med Can 1991; 120:351-3. [PMID: 1962384] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
The efficacy of cochlear implantation as an aid to communication for profoundly hearing impaired persons is now established. International data show that some comprehension without visual cues is possible in many cases. Up to now, the bulk of research has been focused on psychoacoustical and speech perception measures. Hearing handicap changes following an implantation were rarely explored. On a longitudinal study on the benefits of cochlear implantation for twelve adults with profound acquired deafness, we explored the evolution of the hearing loss handicap. Two questionnaires were completed by the participants before and after implantation. A descriptive analysis of the data shows a rather moderate diminution of the handicap. The importance of the diminution appears inversely correlated to the length of deafness.
Collapse
Affiliation(s)
- F Bergeron
- Institut des sourds de Charlesbourg, Québec
| | | |
Collapse
|
32
|
Gonzalez-Muniz R, Cornille F, Bergeron F, Ficheux D, Pothier J, Durieux C, Roques BP. Solid phase synthesis of a fully active analogue of cholecystokinin using the acid-stable Boc-Phe (p-CH2) SO3H as a substitute for Boc-Tyr(SO3H) in CCK8. Int J Pept Protein Res 1991; 37:331-40. [PMID: 1894448 DOI: 10.1111/j.1399-3011.1991.tb00747.x] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/29/2022]
Abstract
Substitution of the -OSO3H group in the sulfated-tyrosine by the non-hydrolyzable-CH2SO3H group was the first described modification of the sulfate ester that does not affect CCK8 activity. In addition to its capacity to mimic the sulfated tyrosine residue, the amino acid Phe(p-CH2SO3Na) was shown to be stable in acidic media, including HF containing mixtures. The synthesis of Boc-Phe(p-CH2SO3Na)-OH in racemic and resolved forms and its introduction into the sequence of CCK8 by solid phase using standard Boc/benzyl synthesis conditions and BOP as coupling reagent is now reported. The two CCK8 analogues containing the L- or the D-Phe(p-CH2SO3Na) residue, obtained in satisfactory yields, were separated by HPLC and the stereochemistry of Phe(p-CH2SO3Na) residue in each peptide was established by NMR spectroscopy and confirmed by a separate solid phase synthesis in which the pure L isomer was used. Both CCK8 analogues displayed high affinities for peripheral and central receptors (KI approximately 1 nM) and proved to be full agonists in the stimulation of pancreatic amylase secretion. The "stabilized-CCK8 peptide", easily prepared by solid phase, could replace the native peptide in biochemical and pharmacological studies. Moreover the modified amino acid Phe (p-CH2SO3Na) could also be used in solid phase synthesis to prepare a wide variety of CCK analogues and more generally, peptides analogues containing the acid-labile O-sulfated tyrosine.
Collapse
Affiliation(s)
- R Gonzalez-Muniz
- Department of Organic Chemistry, U 266 INSERM, UA 498 CNRS, UFR of Pharmaceutical and Biological Sciences, Paris, France
| | | | | | | | | | | | | |
Collapse
|
33
|
Abstract
The respective roles of the benzyloxycarbonyl group (Z) and of the N-terminal tripeptide moiety in the antagonist properties of the cholecystokinin CCK8 analogue Boc-[Nle28,Orn(Z)31]CCK27-33 (Marseigne et al. J. Med. Chem. 1988, 31, 966.) were studied with the following derivatives: Boc-[Nle28,Orn(X)31]CCK27-33, Boc[Nle28,Orn(X)31]CCK27-32, Boc-[Orn(X)31]CCK30-33, and Boc-[Orn(X)31]CCK30-32 (X = Z, Boc, H). These derivatives, the synthesis of eight of which is reported here, were tested for their abilities to inhibit the binding of [3H]pCCK8 to guinea pig pancreatic and brain membranes and for their potencies in stimulating amylase release from guinea pig pancreatic acini. None of the Z derivatives produced amylase secretion, but they competitively antagonized the stimulation induced by CCK8. The deletion of the N-terminal tripeptide and/or Phe-NH2(33) residue did not play a key role in the recognition of peripheral receptors and in the activity of these peptides, whereas replacement of the Z group by a Boc group slightly decreased the affinities of the compounds for both pancreatic and brain binding sites and their potencies as peripheral antagonists. Moreover, the tetrapeptide Boc-Trp-Orn(Boc)-Asp-Phe-NH2 behaved as a partial agonist and analogues in which the Z or Boc groups on the ornithine residue were removed were full agonists. Interestingly, the short peptide derivative Boc-Trp-Orn(Z)-Asp-NH2 displayed the same affinity (KI = 2.0 +/- 0.2 x 10(-7] and the same antagonist activity (pA2 = 6.63) as its parent compound Boc-[Nle28,Orn(Z)31]CCK27-33. This tripeptide could be an interesting tool for studying the structural relationships between peptide and non-peptide CCK antagonists.
Collapse
Affiliation(s)
- R Gonzalez-Muniz
- Département de Chimie Organique, U 266 INSERM, UA 498 CNRS, U.E.R. des Sciences Pharmaceutiques et Biologiques, Paris, France
| | | | | | | | | |
Collapse
|
34
|
Bergeron F, Ferron P, Gobeil S, Desgagné M. Multielectrode cochlear implantation in children: the Quebec experience. J Otolaryngol 1990; 19:324-30. [PMID: 2262951] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
The Quebec Cochlear Implant Research Program has implanted three children since August 1987. This paper reports the results obtained with these children. All of them improved their auditory abilities with cochlear implantation and training. However, the abilities which spontaneously recovered following implantation, the speed of improvement, and the overall level of performance are different from one child to the other. Our data suggest that the age at onset of hearing loss, and possibly the number of years of deafness, may be related to the differences in performance.
Collapse
Affiliation(s)
- F Bergeron
- Institut des Sourds de Charlesbourg, Quebec, Canada
| | | | | | | |
Collapse
|
35
|
Affiliation(s)
- C Durieux
- Département de Chimie Organique, U.266 INSERM, UA 498 CNRS, Paris, France
| | | | | | | |
Collapse
|
36
|
Bergeron F, Ferron P, Desgagné M. Cochlear implantation in Quebec city: auditory performance in a recently trained patient. J Otolaryngol 1989; 18:17-23. [PMID: 2522151] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
The Quebec Cochlear Implant Research Program has implanted nine patients since 1984. At the same time, we have been developing some original rehabilitative material for these French speaking patients. This paper reports the results obtained with our last adult patient. With his implant, J-P.F. has clearly improved his auditory response to sounds. After the training period, he demonstrated good abilities in detection, discrimination, identification and comprehension of sounds, phonemes, words and sentences. His lipreading has improved. The performance observed with this patient is comparable with the data reported in other studies using the same implant device.
Collapse
Affiliation(s)
- F Bergeron
- Institut des Sourds de Charlesbourg, Quebec, Canada
| | | | | |
Collapse
|
37
|
Charest PM, Bergeron F, Lafontaine JG. Ultrastructural localization of DNA and RNA in Allium porrum interphase cells by means of nuclease-gold complexes. Histochem J 1985; 17:957-66. [PMID: 2415492 DOI: 10.1007/bf01417945] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
Nucleic acids have been localized in Allium porrum interphase meristematic cells by means of labelling with nuclease-gold complexes, a technique which provides high resolution and improved specificity. DNase-gold labelling was observed over dense chromatin and to a lesser extent over dispersed chromatin. Nucleolar labelling was restricted to the dense fibrillar component, very few particles being located over the fibrillar centres. Labelling by the RNase-gold complex was present over both the cytoplasm and the nucleoplasm. Cytoplasm labelling was intense over the rough endoplasmic reticulum but absent over vacuoles. In the nucleoplasm many gold particles were located at the border between the condensed and the dispersed chromatin. Nucleolar labelling was intense over the granular zones but many gold particles were also seen over the dense fibrillar component. Fibrillar centres showed, however, no labelling with the RNase-gold complex. These results are consistent with previous autoradiographic and cytochemical observations carried out on the same plant material.
Collapse
|
38
|
Bergeron F, Xénos JB. [Pain: an ailment to be mastered]. Nurs Que 1984; 4:20-7. [PMID: 6565217] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/05/2023]
|
39
|
Kobusch AB, Simard A, Feldstein M, Vauclair R, Gibbs GW, Bergeron F, Morissette N, Davis R. Pulmonary cytology in chrysotile asbestos workers. J Chronic Dis 1984; 37:599-607. [PMID: 6086690 DOI: 10.1016/0021-9681(84)90109-7] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/18/2023]
Abstract
The prevalence of atypical cytology has been determined in relation to age, smoking and asbestos exposure for male workers employed in 3 mines in the Province of Quebec. Overall participation was 71%. Out of 867 participating workers, 626 (72%) presented a deep cough specimen within normal limits, 74 (8.5%) a specimen with mild atypical metaplasia and 10 (1.2%) a specimen with moderate atypical metaplasia. Four lung carcinoma were identified. Five percent of the workers initially interviewed did not return their specimen and 12.7% had unsatisfactory test results. Proportions of cellular atypia increased with age and asbestos exposure. Using logistic regression analysis, estimated probabilities of abnormal cytology for workers aged 25 years when started mining increased with both years of asbestos exposure and exposure index measured in fibres per cubic centimeter.
Collapse
|
40
|
Bergeron F, Grégoire MP. [Nursing care of the dying. A specialty to be developed or a general approach?]. Nurs Que 1983; 3:18-20, 22-3. [PMID: 6559290] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/05/2023]
|
41
|
Bergeron F. [Beneficiaries' ombudsman]. Nurs Que 1982; 2:32-3. [PMID: 6924117] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
|
42
|
Simard A, Vauclair R, Feldstein M, Bergeron F, Morissette N, Band P. Sputum cytology and asbestos exposure: a preliminary report. Recent Results Cancer Res 1982; 82:147-52. [PMID: 7111837 DOI: 10.1007/978-3-642-81768-7_14] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/23/2023]
|
43
|
Bergeron F. [A nurse becomes a patient ombudsman. Interview by Danielle Plerquin]. Krankenpfl Soins Infirm 1981:58. [PMID: 6265696] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
|
44
|
Allen M, Bergeron F, Chevrette J, Custeau D, David N, Ezer H, Giangi C, Grégoire MP, Laplante R, Lessard M, Parent L, Patoine J, Pineault L, Tenn L, Thibault C, Thibaudeau MF, Warner M. [Nursing the patient in his own setting]. Infirm Can 1981; 23:14-7. [PMID: 6906338] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
|